Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia. - Mazzarella R; Cicconi L; Perrone S; Divona MD; Ceccolini S; Nardozza AM; Biagi A; Ottone T; Corbingi A; Panetta P; La Barbera EO; Fiori L; et al. (Annals of hematology, 2026)